We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PreOmics Logo

PreOmics

PreOmics empowers its clients in life science to establish biological knowledge through efficient reliable solutions and workflows that set the standard for protein analysis. A trusted partner with deeply rooted scientific experience.

Latest PreOmics Content

Red and white blood cells in serum, with the Preomics logo at the top of the screen.
Webinar

Unlocking the Plasma Proteome: Advanced Profiling and Biomarker Discovery

Clinical blood analysis is crucial for monitoring health and diagnosing diseases, with blood-based biomarkers playing a key role.
proteomics Webinar featuring, Christof Lenz, PhD & Gregory Potts, PhD
Webinar

Transform Biomedicine and Drug Discovery Through Innovative Proteomics

On-Demand
In this webinar, you’ll hear from Christof Lenz, PhD, about the importance of analyzing tissue samples in biomedical proteomics, particularly for understanding the molecular basis of cardiac diseases. Our second speaker, Greg Potts, PhD, will showcase how chemoproteomics, in combination with data-independent acquisition, speeds up drug discovery.
Preomics logo.
Product News

PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS

PreOmics GmbH announces the launch of its new ENRICHiST™ kits, which enable biologically unbiased enrichment of lower abundant plasma and serum proteins onto non-functionalized paramagnetic particles.
Unlock the Full Potential of FFPE Tissue in Proteomics content piece image
App Note / Case Study

Unlock the Full Potential of FFPE Tissue in Proteomics

Formalin-fixed, paraffin-embedded (FFPE) tissue is a valuable resource in the retrospective proteomic analysis of clinical and non-clinical samples. However, sample preparation techniques typically involve laborious, time-consuming and potentially hazardous xylene-based deparaffinization steps.
PreOmics Announces Closing of Series B Financing content piece image
Product News

PreOmics Announces Closing of Series B Financing

PreOmics GmbH has raised €13.5m in a Series B financing round provided by Bruker Corporation (Nasdaq: BRKR).
Advertisement